ctrl K

Watchlist Price Alert

Centessa Pharmaceuticals (CNTA)

NASDAQ: CNTA · Real-Time Price · USD

13.07

0.12 (0.93%)

At close: May 29, 2025, 3:59 PM

13.30

1.76%

After-hours: May 29, 2025, 07:15 PM EDT

Centessa Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2021
Lixivaptan Revenue	200M
Lixivaptan Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	12.33M	13.71M	12.5M	11.16M	13.19M	12.17M	12.02M	13.35M	16.05M	13.77M	12.28M	14.76M	14.38M	12.99M	12.46M	11.84M	8.24M	308K	193K	258K	383K
Selling, General, and Administrative Revenue Growth	-10.01%	+9.63%	+11.97%	-15.36%	+8.35%	+1.29%	-9.94%	-16.85%	+16.58%	+12.08%	-16.79%	+2.63%	+10.76%	+4.20%	+5.26%	+43.71%	+2575.15%	+59.59%	-25.19%	-32.64%	n/a
Research and Development Revenue	33.44M	60.89M	33.9M	32.81M	22.64M	29.97M	28.19M	33.67M	32.83M	27.84M	36.74M	53.65M	36.85M	41.53M	25.85M	18.13M	10.78M	994K	2.57M	1.87M	3.33M
Research and Development Revenue Growth	-45.07%	+79.59%	+3.32%	+44.95%	-24.47%	+6.33%	-16.28%	+2.58%	+17.93%	-24.25%	-31.51%	+45.58%	-11.27%	+60.67%	+42.55%	+68.23%	+984.43%	-61.38%	+37.57%	-43.86%	n/a